CLARIVATE PLC (CLVT)

NYSE
Currency in USD
4.29
-0.12(-2.72%)
Closed·
After Hours
4.30+0.01(+0.23%)
·
CLVT Scorecard
Full Analysis
Management has been aggressively buying back shares
CLVT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.264.38
52 wk Range
3.047.15
Key Statistics
Edit
Prev. Close
4.41
Open
4.38
Day's Range
4.26-4.38
52 wk Range
3.04-7.15
Volume
3.78M
Average Vol. (3m)
5.85M
1-Year Change
-22.84%
Book Value / Share
7.3
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLVT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.31
Upside
+23.67%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

CLARIVATE PLC News & Analysis

Show more

CLARIVATE PLC Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

CLARIVATE PLC SWOT Analysis


Market Valuation
Analysts offer mixed views on Clarivate's prospects, with price targets ranging from $4.00 to $6.00, reflecting uncertainty in the company's turnaround efforts
Strategic Shifts
Delve into Clarivate's transition from transactional to subscription-based revenue models, a move aimed at long-term stability but with short-term risks
IP Segment Potential
Explore the growth opportunities in Clarivate's Intellectual Property division, expected to benefit from favorable comparisons and patent renewal timing
Turnaround Challenges
Clarivate faces headwinds as it implements a new Value Creation Plan amid declining revenues and slowing subscription growth in its Analytics & Governance segment
Read full SWOT analysis

CLARIVATE PLC Earnings Call Summary for Q4/2024

  • Q4 2024 adjusted EPS of $0.21 beat expectations, but revenue of $663M missed forecasts; stock dipped 1.35% pre-market
  • Full-year 2024 revenue reached $2.56B with $0.73 EPS; company transitioning to subscription model with new product innovations
  • 2025 guidance: Revenue $2.34B, adjusted EBITDA $940M-$1B, EPS $0.60-$0.70, free cash flow ~$340M
  • Strategic focus on improving operational performance and returning to healthy organic growth; Q4 organic revenue decline improved to 0.7%
  • CEO emphasizes aggressive moves to improve performance and create shareholder value; CFO confident in value creation plan
Last Updated: 02/19/2025, 10:10 AM
Read Full Transcript

Compare CLVT to Peers and Sector

Metrics to compare
CLVT
Peers
Sector
Relationship
P/E Ratio
−4.3x19.7x12.0x
PEG Ratio
−0.110.390.03
Price / Book
0.6x3.1x1.4x
Price / LTM Sales
1.2x1.1x1.2x
Upside (Analyst Target)
17.9%12.0%17.8%
Fair Value Upside
Unlock15.9%7.6%Unlock

Analyst Ratings

5 Buy
4 Hold
1 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.31
(+23.67% Upside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
0.14 / 0.12
Revenue / Forecast
593.70M / 577.45M
EPS Revisions
Last 90 days

CLVT Income Statement

People Also Watch

202.57
EXP
+2.22%
301.11
WTW
+1.74%
26.72
GDS
-0.63%
111.84
DG
+0.35%

FAQ

What Is the CLARIVATE (CLVT) Stock Price Today?

The CLARIVATE stock price today is 4.29

What Stock Exchange Does CLARIVATE Trade On?

CLARIVATE is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for CLARIVATE?

The stock symbol for CLARIVATE is "CLVT."

What Is the CLARIVATE Market Cap?

As of today, CLARIVATE market cap is 2.92B.

What Is CLARIVATE's Earnings Per Share (TTM)?

The CLARIVATE EPS (TTM) is -0.97.

When Is the Next CLARIVATE Earnings Date?

CLARIVATE will release its next earnings report on Jul 31, 2025.

From a Technical Analysis Perspective, Is CLVT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has CLARIVATE Stock Split?

CLARIVATE has split 2 times.

How Many Employees Does CLARIVATE Have?

CLARIVATE has 12000 employees.

What is the current trading status of CLARIVATE (CLVT)?

As of Jun 13, 2025, CLARIVATE (CLVT) is trading at a price of 4.29, with a previous close of 4.41. The stock has fluctuated within a day range of 4.26 to 4.38, while its 52-week range spans from 3.04 to 7.15.

What Is CLARIVATE (CLVT) Price Target According to Analysts?

The average 12-month price target for CLARIVATE is USD5.30556, with a high estimate of USD7 and a low estimate of USD4. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +23.67% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.